Skip to content

Correlation of eye movements with blood markers, urinary neurofilament protein and functional magnetic resonance imaging in patients with mild Alzheimer's disease

Correlation study of eye movement with blood markers, urinary neurofilament protein and functional magnetic resonance in mild Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064665
Enrollment
Unknown
Registered
2022-10-13
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease

Interventions

Mild AD:None
Depression in old age:None

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for mild AD patients: (1) The patients who visited the memory clinic of our hospital met the diagnostic criteria of AD formulated by NIA-AA, had no metal implants, pacemakers, etc., and had no history of sedative and alcohol intake; (2) More than 8 years of education, age >=65 years; (3) Mini-mental state examination (MMSE) =65 years; (3) Hamilton Depression Scale (HAMD-17) > 7; (4) Mini-mental state examination (MMSE) =65 years; (3) No visual or hearing impairment; (4) Mini-mental state examination (MMSE) >=26 points; (5) Montreal Cognitive Assessment Scale (MoCA) score > 26; (6) Clinical Dementia Scale (CDR) = 0; (7) Hamilton Depression Scale (HAMD-17) < 7; (8) Daily behavior of life ability is normal; (9) Right-handed.

Exclusion criteria

Exclusion criteria: 1. Medical history that may affect cognition was investigated, excluding cerebrovascular disease (cerebral infarction, cerebral hemorrhage), vascular dementia, cerebral small vessel disease, thyroid dysfunction, epilepsy, Parkinson's disease, malnutrition, long-term diarrhea, severe liver and kidney insufficiency, carbon monoxide poisoning, craniocerebral trauma, alcohol poisoning, etc.

Design outcomes

Primary

MeasureTime frame
Depending on the eye;Neuropsychological scale;Structural brain MRI;Functional brain MRI;Blood Aß42, tau protein;Urine AD7C - the NTP;

Countries

China

Contacts

Public ContactZeng Yanfang

Beijing Luhe Hospital, Capital Medical University

zyf2075697@sina.com+86 13641069765

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026